Innovation
Mon, Jul 28, 2025 8:32 AM

Egis Invests Over HUF 14 Billion in Körmend Site Development

As part of its ongoing development program, Egis Pharmaceuticals PLC is investing over HUF 14 billion to expand its Körmend site. The project, supported by HUF 3.5 billion in government funding, will increase production capacities and modernise technological infrastructure, further strengthening the strategic importance of the facility.
Innovation

Egis Invests Over HUF 14 Billion in Körmend Site Development

As part of its ongoing development program, Egis Pharmaceuticals PLC is investing over HUF 14 billion to expand its Körmend site. The project, supported by HUF 3.5 billion in government funding, will increase production capacities and modernise technological infrastructure, further strengthening the strategic importance of the facility.
Mon, Jul 28, 2025 8:32 AM
Author:
Mon, Jul 28, 2025 8:32 AM
Author:

At a joint press conference held on July 28, 2025 by Egis and the Ministry of Foreign Affairs and Trade, it was announced that the investment aims to expand manufacturing, packaging, and storage capacities, while also upgrading the site's technological infrastructure.

This development is closely aligned with Egis’s ongoing modernization efforts, which include upgrading the tablet production unit, the infrastructure for galenic preparations (non-solid pharmaceutical forms such as creams, ointments, gels, suppositories, and solutions), and the packaging unit, along with increasing their capacities. These improvements will enhance the Körmend site’s strategic role within the company and enable Egis to respond more swiftly and flexibly to changing market demands.

“This development not only increases our production capacity but also represents a technological renewal, allowing us to operate more efficiently and sustainably. This is the key to competitiveness, which has always characterized Egis alongside its innovative approach,” said Csaba Poroszlai, CEO of Egis Pharmaceuticals PLC. He emphasized that the company aims to apply the best available technologies and tools:“These not only meet the strictest inte rnational standards but also significantly enhance efficiency, thereby boosting the company’s competitiveness and ultimately contributing to the performance of the Hungarian economy.”

Over the past years, Egis has continuously and intensively developed its Körmend site, where nearly HUF 29 billion worth of investments have been made since 2018, creating jobs with government support. Together with the newly announced developments, these efforts will define and secure the future of pharmaceutical manufacturing in the region for the long term.

Related articles from Egis Magazine
Innovation

Our project aimed at developing oncological active ingredients and preparations has concluded successfully
More
Innovation

Development of Innovative, High Value-Added Oncological Drug Products for Personalized Therapies
More
Innovation

Egis' medicines won the Innovation Grand Prize
More

Cookie Settings

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Cookies necessary for basic functioning

These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

Functional cookies

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.

Cookies for statistical purposes

They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Details
I Agree
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox